Latest Period
Q1 2026
Security Snapshot
CVRx, Inc. - Common Stock, $0.01 par value (CVRX) Institutional Ownership
CUSIP: 126638105
13F Institutional Holders and Ownership History from Q2 2021 to Q1 2026
Institutions Reporting
98
Shares (Excl. Options)
14,691,674
Price
$9.46
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, $0.01 par value
- Symbol
- CVRX on Nasdaq
- Shares outstanding
- 26,135,461
- Price per share
- $6.87
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 14,691,674
- Total reported value
- $138,937,436
- % of total 13F portfolios
- 0%
- Share change
- -573,979
- Value change
- -$3,699,641
- Number of holders
- 98
- Price from insider filings
- $6.87
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- CVRX - CVRx, Inc. - Common Stock, $0.01 par value is tracked under CUSIP 126638105.
- 98 institutions reported positions in Q1 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 90 to 98 between Q4 2025 and Q1 2026.
- Reported value moved from $108,000,876 to $138,937,436.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 98 institutions filings for Q1 2026.
Security key
126638105
Latest holder period
Q1 2026
13F holders
98
13D/G owners
4
CIK / CUSIP context first
Open Q1 2026 holders
CVRX full holder history
CVRx, Inc. SEC filings
CVRx, Inc. company facts
CVRx, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 126638105:
Significant Owners of CVRx, Inc. - Common Stock, $0.01 par value (CVRX) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| JOHNSON & JOHNSON | 15% | $28,578,928 | 4,024,861 | JOHNSON & JOHNSON | 31 Dec 2025 | |||
| NEW ENTERPRISE ASSOCIATES 10 L P | 7.8% | $13,635,539 | 2,026,083 | New Enterprise Associates 10, Limited Partnership | 18 Feb 2025 | |||
| Vensana Capital I GP, LLC | 7.2% | $11,849,740 | 1,760,734 | Kirk Nielsen | 31 Dec 2024 | |||
| Cooperatieve Gilde Healthcare IV U.A. | 4.9% | $8,287,928 | 1,231,490 | Cooperatieve Gilde Healthcare IV U.A. | 04 Feb 2025 |
As of 31 Mar 2026, 98 institutional investors reported holding 14,691,674 shares of CVRx, Inc. - Common Stock, $0.01 par value (CVRX). This represents 56% of the company’s total 26,135,461 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of CVRx, Inc. - Common Stock, $0.01 par value (CVRX) together control 53% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| JOHNSON & JOHNSON | 15% | 4,024,861 | 0% | 5.8% | $38,075,185 |
| NEA Management Company, LLC | 7.8% | 2,026,083 | 0% | 1.1% | $19,166,745 |
| BlackRock, Inc. | 3.9% | 1,026,559 | -3.3% | 0% | $9,711,248 |
| GSK plc | 3.9% | 1,007,583 | 0% | 1.6% | $9,531,735 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.5% | 911,310 | 0% | 0% | $8,620,993 |
| ROYAL BANK OF CANADA | 2.7% | 706,928 | +6559% | 0% | $6,688,000 |
| Balyasny Asset Management L.P. | 2.4% | 630,812 | -23% | 0.01% | $5,967,481 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 2.2% | 572,021 | -9.9% | 0.04% | $5,411,319 |
| Parkman Healthcare Partners LLC | 1.6% | 429,507 | +4% | 0.42% | $4,063,136 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 427,072 | +5.7% | 0% | $4,041,543 |
| STATE STREET CORP | 1.3% | 350,548 | +12% | 0% | $3,316,184 |
| FourWorld Capital Management LLC | 0.89% | 231,996 | +29% | 1.2% | $2,194,682 |
| GOLDMAN SACHS GROUP INC | 0.77% | 201,011 | +13% | 0% | $1,901,564 |
| TUDOR INVESTMENT CORP ET AL | 0.76% | 197,340 | +25% | 0.01% | $1,866,836 |
| NORTHERN TRUST CORP | 0.57% | 150,123 | +8.9% | 0% | $1,420,164 |
| MORGAN STANLEY | 0.53% | 139,364 | -63% | 0% | $1,318,384 |
| VANGUARD FIDUCIARY TRUST CO | 0.49% | 127,761 | 0% | 0% | $1,208,619 |
| Quantinno Capital Management LP | 0.44% | 115,818 | +52% | 0% | $1,095,638 |
| TWO SIGMA INVESTMENTS, LP | 0.44% | 114,167 | +367% | 0% | $1,080,020 |
| Cresset Asset Management, LLC | 0.41% | 106,349 | +48% | 0% | $1,006,062 |
| UBS Group AG | 0.4% | 103,810 | +17% | 0% | $982,043 |
| BNP PARIBAS FINANCIAL MARKETS | 0.38% | 98,670 | 0% | 0% | $933,418 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.36% | 94,849 | 0% | 0% | $897,272 |
| AQR CAPITAL MANAGEMENT LLC | 0.34% | 89,904 | 0% | $850,491 | |
| GSA CAPITAL PARTNERS LLP | 0.22% | 57,538 | -69% | 0.03% | $544,000 |
Institutional Holders of CVRx, Inc. - Common Stock, $0.01 par value (CVRX) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 14,691,674 | $138,937,436 | -$3,699,641 | $9.46 | 98 |
| 2025 Q4 | 15,210,504 | $108,000,876 | +$1,422,903 | $7.10 | 90 |
| 2025 Q3 | 14,003,450 | $113,001,810 | -$4,140,662 | $8.07 | 91 |
| 2025 Q2 | 14,566,804 | $85,403,778 | -$19,986,146 | $5.88 | 91 |
| 2025 Q1 | 15,971,769 | $195,337,855 | +$10,778,190 | $12.23 | 95 |
| 2024 Q4 | 15,154,273 | $192,128,165 | +$11,666,171 | $12.67 | 91 |
| 2024 Q3 | 14,208,138 | $125,172,924 | +$5,810,039 | $8.81 | 84 |
| 2024 Q2 | 13,192,379 | $158,176,281 | -$11,196,197 | $11.99 | 72 |
| 2024 Q1 | 13,441,680 | $244,665,057 | +$21,036,083 | $18.21 | 87 |
| 2023 Q4 | 12,015,323 | $377,446,209 | +$6,898,602 | $31.44 | 83 |
| 2023 Q3 | 11,953,961 | $181,343,253 | +$2,863,854 | $15.17 | 64 |
| 2023 Q2 | 11,594,427 | $179,048,989 | +$23,946,250 | $15.44 | 66 |
| 2023 Q1 | 10,400,213 | $96,928,042 | -$20,701,454 | $9.32 | 61 |
| 2022 Q4 | 10,299,118 | $188,989,468 | +$3,540,115 | $18.35 | 48 |
| 2022 Q3 | 10,529,611 | $98,240,851 | -$6,931,505 | $9.33 | 37 |
| 2022 Q2 | 10,888,954 | $65,444,210 | -$7,076,705 | $6.01 | 34 |
| 2022 Q1 | 12,073,187 | $72,317,176 | -$14,166,594 | $5.99 | 55 |
| 2021 Q4 | 12,884,491 | $157,579,777 | -$25,347,085 | $12.23 | 53 |
| 2021 Q3 | 11,758,612 | $194,426,346 | -$15,245,912 | $16.54 | 49 |
| 2021 Q2 | 13,787,189 | $386,044,000 | +$386,044,000 | $28.00 | 59 |